| The landscape of cancer genes and mutational processes in breast cancer PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ... Nature 486 (7403), 400-404, 2012 | 1853 | 2012 |
| Estimation of the warfarin dose with clinical and pharmacogenetic data International Warfarin Pharmacogenetics Consortium New England Journal of Medicine 360 (8), 753-764, 2009 | 1771 | 2009 |
| Pan-cancer analysis of whole genomes I The, TPCA of Whole, Genomes Consortium Nature 578 (7793), 82, 2020 | 1326 | 2020 |
| Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing JA Johnson, L Gong, M Whirl‐Carrillo, BF Gage, SA Scott, CM Stein, ... Clinical Pharmacology & Therapeutics 90 (4), 625-629, 2011 | 741 | 2011 |
| A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity HY Yuan, JJ Chen, MTM Lee, JC Wung, YF Chen, MJ Charng, MJ Lu, ... Human molecular genetics 14 (13), 1745-1751, 2005 | 692 | 2005 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics‐guided warfarin dosing: 2017 update JA Johnson, KE Caudle, L Gong, M Whirl‐Carrillo, CM Stein, SA Scott, ... Clinical Pharmacology & Therapeutics 102 (3), 397-404, 2017 | 560 | 2017 |
| Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups NA Limdi, M Wadelius, L Cavallari, N Eriksson, DC Crawford, MTM Lee, ... Blood, The Journal of the American Society of Hematology 115 (18), 3827-3834, 2010 | 554* | 2010 |
| Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process K E Caudle, T E Klein, J M Hoffman, D J Muller, M Whirl-Carrillo, L Gong, ... Current drug metabolism 15 (2), 209-217, 2014 | 407 | 2014 |
| Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen‐B Genotype and Allopurinol Dosing MS Hershfield, JT Callaghan, W Tassaneeyakul, T Mushiroda, CF Thorn, ... Clinical Pharmacology & Therapeutics 93 (2), 153-158, 2013 | 283 | 2013 |
| Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing KE Caudle, AE Rettie, M Whirl-Carrillo, LH Smith, S Mintzer, MTM Lee, ... Clinical Pharmacology & Therapeutics 96 (5), 542-548, 2014 | 258 | 2014 |
| Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations CG Boer, K Hatzikotoulas, L Southam, L Stefánsdóttir, Y Zhang, ... Cell, 2021 | 212 | 2021 |
| Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes MS Wen, MTM Lee, JJ Chen, HP Chuang, LS Lu, CH Chen, TH Lee, ... Clinical Pharmacology & Therapeutics 84 (1), 83-89, 2008 | 201 | 2008 |
| Use of HLA-B* 58: 01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study TM Ko, CY Tsai, SY Chen, KS Chen, KH Yu, CS Chu, CM Huang, ... Bmj 351, 2015 | 193 | 2015 |
| CYP2D6 Genotype and Adjuvant Tamoxifen: Meta‐Analysis of Heterogeneous Study Populations MA Province, MP Goetz, H Brauch, DA Flockhart, JM Hebert, R Whaley, ... Clinical Pharmacology & Therapeutics 95 (2), 216-227, 2014 | 190 | 2014 |
| The landscape of cancer genes and mutational processes in breast cancer. C Latimer, I Varela, A Broeks, PV Loo, E Papaemmanuil, BTK Tee, ... Nature, 2012 | 188 | 2012 |
| Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat-or CCR5-specific small interfering RNAs expressed from a lentivirus vector MTM Lee, GA Coburn, MO McClure, BR Cullen Journal of virology 77 (22), 11964-11972, 2003 | 188 | 2003 |
| Variant GADL1 and Response to Lithium Therapy in Bipolar I Disorder CH Chen, CS Lee, MTM Lee, WC Ouyang, CC Chen, MY Chong, JY Wu, ... New England Journal of Medicine 370 (2), 119-128, 2014 | 181 | 2014 |
| Genome-wide association study of bipolar I disorder in the Han Chinese population MTM Lee, CH Chen, CS Lee, CC Chen, MY Chong, WC Ouyang, NY Chiu, ... Molecular psychiatry 16 (5), 548-556, 2011 | 170 | 2011 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA‐B) genotype and allopurinol dosing: 2015 update Y Saito, LK Stamp, KE Caudle, MS Hershfield, EM McDonagh, ... Clinical Pharmacology & Therapeutics 99 (1), 36-37, 2016 | 144 | 2016 |
| Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease W Zhou, M Kanai, KHH Wu, H Rasheed, K Tsuo, JB Hirbo, Y Wang, ... Cell Genomics 2 (10), 100192, 2022 | 137 | 2022 |
Teri E. KleinStanford UniversityDirección de correo verificada de stanford.edu
